NIFTY 15500 PE OF 26 MAY MONTH EXPIRY


BUY NEAR 110---115


SL 97


TGT 133--40--44-46-50++

NIFTY 15500 PE OF 26 MAY MONTH EXPIRY




128.90



🚀🚀🚀🚀🚀🍎🍎🎉

NIFTY 15500 PE OF 26 MAY MONTH EXPIRY


133.20


First Target Achieved



🚀🚀🚀🚀🚀🍎🍎🍎🍎🎉🎉😘

NIFTY 15500 PE OF 26 MAY MONTH EXPIRY

112

To

152


ALL Target Achieved✅



🚀🚀🚀🚀🚀🍎🍎🍎🍎🎉🎉😘

NIFTY IS BULLISH NOW


BUT


NOT STRENGTH IN BUYING.

LOOKING WEAK.


WAIT FOR RIGHT OPPORTUNITIES.

NOW JUST WAIT AND WATCH.


🙏🙏

THERE’S NO FERTILISER SHORTAGE IN INDIA,
MINISTRY ESTIMATES REDUCTION IN USAGE OF 20 LAKH TONNES OF UREA THIS YEAR, SAYS FERTILISER MINISTER

#BreakingNews

VISHNU CHEMICALS Q4FY22 Earnings Call Highlights
Scaling up!



Domestic and exports sales grew by 56% and 58% respectively in the last 12 months. Demand environment is as good as it gets.

Expansion of +317bps in EBITDA margin y-o-y was aided by scale, paramount quality, operational flexibility,emphasis on supply chain and strengthened procurement planning.

Increase of 20% in Chromium volumes on FY20 base, 22% from FY21. Increase of 10% in Barium volumes in FY22.

Can maintain and also improve EBITDA Margins of FY22 in FY23.

In Q4, registered 9.5% EBITDA Margins in Barium Chemicals, decided to absorb the prices. Increased prices effectively from April. Margins are sustainable in the range of 15-20%. 15% contribution to total sales.

Excited to venture into new product in Barium Chemicals, which is Import Substitute, allocated 90Cr out of 120Cr in FY23, would be commissioned by H1FY24.

Also expanding in Chromium Chemicals, spending 30Cr to expand capacity from 70K to 80K. Will start operations by end of Q2FY23, will see improvement of volumes of atleast 10%.

Gross margin improvement of 300-400 bps from backward integration.

Looking at 40% increase in Barium Volumes in FY23, to see better margins as operating leverage kicks in.

Have a strong peer in Russia that is facing difficulty to sell chemicals.

Don’t expect lot of capacity additions globally in next 18-24 months, exports from China not a concern.

Targeting ROCE upwards of 30% in coming years.

Utilisation in Chromium at 90% and 85% in Barium.

Moving to solar power in Vishnu Barium to secure energy needs.
Twitter fwd

NIFTY FUTURE OF 26 MAY

DOWNSIDE POSSIBLE

BELOW 16275.


Keep watch

NIFTY FUTURE OF 26 MAY

DOWNSIDE POSSIBLE

BELOW 16275.


CMP 16320--25


RISKY TRADER CAN SHORT WITH SL 16355


TGT 16280--75-70-60-55-50+++++

NIFTY FUTURE OF MONTH EXPIRY



16297



⬇️⬇️⬇️⬇️🍎🍎🍎🍎🎉🎉🎉

NIFTY FUTURE OF 26 MAY


16270




THIRD TARGET ACHIEVED



🍎🍎⬇️⬇️⬇️🎉🎉🎉🍎🍎🙏🙏

NIFTY FUTURE OF 26 MAY


16257




5th TARGET ACHIEVED



🍎🍎⬇️⬇️⬇️🎉🎉🎉🍎🍎🙏🙏

NIFTY FUTURE OF 26 MAY

16320



To


16185😘




ALL TARGET ACHIEVED



🍎🍎⬇️⬇️⬇️🎉🎉🎉🍎🍎🙏🙏

Do not trade like addicted people.


Trade only with opportunities




🎉🎉🎉🎉🎉🎉🍎🍎🍎🙏🙏🙏

Market is down as expected.

Now only wait and watch.


In November sent many mgs regarding market it will be bearish for next 1.5 years.


Some people asking me that why you are not giving delivery calls now.

If I recommend then stop loss will hit because of bearish market then they will say I made loss because of your call😀


Market is not closed for forever

Wait for right opportunity

Trade less

Follow Disciplines

If I found opportunity then I will send you definitely.


Yesterday I recommend to short nifty and it's down.
If today found any opportunity I will share soon 🙏

Loss On Trading In Derivatives Of Securities Not A Speculative Loss, Can Be Set Off Against Business Income: Bombay High Court https://www.livelaw.in/news-updates/bombay-high-court-income-tax-act-itat-finance-act-assessing-officer-ao-199490

*Daily Market Update - 20th May 2022*

*Global Market*

Equities in Asia and U.S, futures rose on Friday amid concerns over global economic outlook and China’s Covid struggles.

Stocks gained in Japan, South Korea and Australia, after Wall Street shares saw modest gains on Thursday. The Singapore-traded SGX Nifty, an early barometer of India's benchmark Nifty 50, rose nearly 1% to 15,940.50 points as of 6:20 am.

Oil hovered near $112 a barrel, gold held a rally and Bitcoin was near $30,000.

*Indian ADR Check*

·         ICICI Bank         -0.34%

·         HDFC Bank      -0.49%

·         Tata Motors        -0.38%

·         WIPRO               -1.66%

·         Infosys               -0.80%

·         Dr Reddy's         +2.74%

*Earnings Post Market Hours*

*Godrej Consumer Products Q4 FY22 (Consolidated, YoY)*

Revenue up 7% at Rs 2915.82 crore Vs Rs 2,730.74 (Bloomberg Estimate: Rs 2,905.64)

EBITDA fell 15% at Rs 467.58 crore Vs Rs 549 crore (Bloomberg Estimate: Rs 567.36 crore)

EBITDA margin 16% Vs 20.1% (Bloomberg Estimate: 19.5%)

Net profit fell 1% at Rs 363.24 crore Vs Rs 365.84 crore (Bloomberg Estimate: Rs 398.12 crore)

*Gland Pharma Q4 FY22 (Consolidated, YoY)*

Revenue up 24% at Rs 1,103 crore Vs Rs 888 crore (Bloomberg estimate: Rs 1,089 crore)

EBITDA up 6% to Rs 348 crore from Rs 328 crore (Bloomberg estimate: Rs 413 crore Profit)

Margins at 31.6% Vs 36.9% (Bloomberg estimate: 37.9%)

Net profit up 10% to Rs 286 crore Vs Rs 260 crore (Bloomberg estimate: Rs 297 crore)

*Ashok Leyland Q4 FY22 (Consolidated, YoY)*

Revenue up 22% at Rs 9,926.97 crore Vs Rs 8,142.11 crore

EBITDA up 17.8% at Rs 1,194.11 crore Vs Rs 1013.3 crore

EBITDA margin 12.03% Vs 12.45%

Net profit fell 60.22% at Rs 140.24 crore Vs Rs 352.56 crore. Exceptional loss on account of impairment of goodwill and assets was Rs 236.91 crore in Q4 FY22.

Recommended dividend of Rs 1 per share of face value of Rs 1 each.

Appointed Rajesh Sethuraman as Chief Executive Officer of ASEAN and Vijay Kannan as Head of Business Transformation and Digital.

*Container Corporation of India Q4 FY22 (Consolidated, YoY)*

Revenue up 5.16% at Rs 2,057.56 crore Vs Rs 1,956.69 crore

EBITDA up 112.53% at Rs 415.84 crore Vs Rs 195.66 crore

EBITDA margin 20.21% Vs 10% (Bloomberg Estimate:

Net profit up 900% at Rs 257.56 crore Vs Rs 25.76 crore

Recommended final dividend of Rs 3 per share of face value of Rs 5 each

*HPCL Q4 FY22 (Consolidated, YoY)*

Revenue up 30.4% at Rs 97,288.11 crore Vs Rs 74,605.76 crore (Bloomberg Estimate: Rs 1,12,700 crore)

EBITDA fell 58.86% at Rs 1,825.53 crore Vs Rs 4,437.81 crore (Bloomberg Estimate: Rs 2,918.4 crore)

EBITDA margin 1.74% Vs 5.22% (Bloomberg Estimate: 2.58%)

Net profit fell 34% at Rs 2,018.45 crore Vs Rs 3,060.7 crore (Bloomberg Estimate: Rs 1,375.8 crore)

Recommended final dividend of Rs 14 per share of face value of Rs 10 each

*Krishna Institute of Medical Sciences Q4 FY22 (Consolidated, QoQ)*

Revenue fell 5.4% at Rs 372.33 crore Vs Rs 393.56 crore

EBITDA fell 12.5% at Rs 113.56 crore Vs Rs 129.74 crore

EBITDA margin 30.5% Vs 32.97%

Net profit fell 0.6% at Rs 80.68 crore Vs Rs 81.17 crore

*Endurance Technologies Q4 FY22 (Consolidated, QoQ)*

Revenue up 10.04% at Rs 2,078.79 crore Vs Rs 1,889.12 crore

EBIT up 42.16% at Rs 159.01 crore Vs Rs 111.85 crore

EBIT margin 7.65% Vs 5.92%

Net profit up 44% at Rs 136.18 crore Vs Rs 94.63 crore

Recommended dividend of Rs 6.25 per share of face value of Rs 10 each

*Chambal Fertilisers & Chemicals Q4 FY22 (Consolidated, YoY)*

Revenue up 101.5% at Rs 3,307.37 crore Vs Rs 1640.76 crore

EBITDA up 26.55% at Rs 361.43 crore Vs Rs 285.6 crore

EBITDA margin 10.93% Vs 17.41%

Net profit fell 45.62% at Rs 243.57 crore Vs Rs 447.89 crore

Recommended final dividend of Rs 3 per share of face value of Rs 10 each

*Prince Pipes and Fittings Q4 FY22 (Consolidated, YoY)*

Revenue up 18.37% at Rs 901.19 crore Vs Rs 761.35 crore

EBITDA fell 4.29% at Rs 140.50 crore Vs Rs 146.79 crore

EBITDA margin 15.6% Vs 19.28%